TR201720515A2 - Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu - Google Patents
Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu Download PDFInfo
- Publication number
- TR201720515A2 TR201720515A2 TR2017/20515A TR201720515A TR201720515A2 TR 201720515 A2 TR201720515 A2 TR 201720515A2 TR 2017/20515 A TR2017/20515 A TR 2017/20515A TR 201720515 A TR201720515 A TR 201720515A TR 201720515 A2 TR201720515 A2 TR 201720515A2
- Authority
- TR
- Turkey
- Prior art keywords
- dosage form
- oral dosage
- solid oral
- form containing
- containing linagliptin
- Prior art date
Links
- LTXREWYXXSTFRX-QGZVFWFLSA-N Linagliptin Chemical compound N=1C=2N(C)C(=O)N(CC=3N=C4C=CC=CC4=C(C)N=3)C(=O)C=2N(CC#CC)C=1N1CCC[C@@H](N)C1 LTXREWYXXSTFRX-QGZVFWFLSA-N 0.000 title abstract 2
- 229960002397 linagliptin Drugs 0.000 title abstract 2
- 239000006186 oral dosage form Substances 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- 239000011230 binding agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Mevcut buluş, linagliptin ve en az bir bağlayıcı içeren katı oral dozaj formu ile ilgilidir.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/20515A TR201720515A2 (tr) | 2017-12-15 | 2017-12-15 | Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu |
PCT/TR2018/050812 WO2019203755A2 (en) | 2017-12-15 | 2018-12-14 | A solid oral dosage form comprising linagliptin |
CA3085455A CA3085455C (en) | 2017-12-15 | 2018-12-14 | A solid oral dosage form comprising linagliptin |
EP18914956.0A EP3723761A4 (en) | 2017-12-15 | 2018-12-14 | SOLID ORAL DOSAGE FORM WITH LINAGLIPTIN |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/20515A TR201720515A2 (tr) | 2017-12-15 | 2017-12-15 | Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201720515A2 true TR201720515A2 (tr) | 2019-07-22 |
Family
ID=67900883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2017/20515A TR201720515A2 (tr) | 2017-12-15 | 2017-12-15 | Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3723761A4 (tr) |
CA (1) | CA3085455C (tr) |
TR (1) | TR201720515A2 (tr) |
WO (1) | WO2019203755A2 (tr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022173406A1 (en) * | 2021-02-15 | 2022-08-18 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A process for formulations of linagliptin or a pharmaceutically acceptable salt thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY32427A (es) * | 2009-02-13 | 2010-09-30 | Boheringer Ingelheim Internat Gmbh | Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma |
WO2013128379A2 (en) | 2012-02-27 | 2013-09-06 | Dr. Reddy's Laboratories Limited | Crystalline polymorphic forms of linagliptin |
WO2014056942A1 (en) * | 2012-10-09 | 2014-04-17 | Boehringer Ingelheim International Gmbh | Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets |
WO2014080384A1 (en) | 2012-11-26 | 2014-05-30 | Ranbaxy Laboratories Limited | Pharmaceutical composition of linagliptin |
WO2014080383A1 (en) * | 2012-11-26 | 2014-05-30 | Ranbaxy Laboratories Limited | Pharmaceutical composition of dipeptidyl peptidase-iv (dpp-iv) inhibitors in combination with other antidiabetics |
CN106138059A (zh) | 2015-03-27 | 2016-11-23 | 天津汉瑞药业有限公司 | 一种稳定的利格列汀药物组合物 |
EP3156048A1 (en) | 2015-10-13 | 2017-04-19 | Galenicum Health S.L. | Stable pharmaceutical composition of linagliptin in the form of immediate release tablets |
-
2017
- 2017-12-15 TR TR2017/20515A patent/TR201720515A2/tr unknown
-
2018
- 2018-12-14 EP EP18914956.0A patent/EP3723761A4/en active Pending
- 2018-12-14 CA CA3085455A patent/CA3085455C/en active Active
- 2018-12-14 WO PCT/TR2018/050812 patent/WO2019203755A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3085455A1 (en) | 2019-10-24 |
CA3085455C (en) | 2022-08-16 |
EP3723761A4 (en) | 2021-06-30 |
EP3723761A2 (en) | 2020-10-21 |
WO2019203755A2 (en) | 2019-10-24 |
WO2019203755A3 (en) | 2020-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121390T1 (el) | Πυρρολοβενζοδιαζεπινες και συζευγματα αυτων | |
TR201900331T4 (tr) | Bir aerosol - üretici sistem için kartuş. | |
MA43187A (fr) | Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations | |
TR201910636T4 (tr) | Bir aerosol - üretici sistem için kartuş ve cihaz. | |
CY1123920T1 (el) | Αντιγριπικο πολυκυκλικο παραγωγο πυριδονης και προφαρμακο αυτου | |
MA45809A (fr) | Promédicaments de pth | |
CY1124425T1 (el) | Συνθεσεις οι οποιες περιλαμβανουν συζευγματα φαρμακου αντισωματος-δουοκαρμυκινης | |
CY1123194T1 (el) | Νεες αντιβακτηριακες ενωσεις | |
CY1123465T1 (el) | Αντιβακτηριακες ενωσεις ευρεως φασματος | |
TR201904120T4 (tr) | Konnektör parçası. | |
UY37153A (es) | Sulfonilamidas sustituidas para combatir parásitos animales | |
TR201901516T4 (tr) | Nöroprotektif ajanlar ve bunların kullanımları. | |
CY1123408T1 (el) | Φαρμακευτικες συνθεσεις και χρηση των αυτων | |
TR201720515A2 (tr) | Li̇nagli̇pti̇n i̇çeren bi̇r kati oral dozaj formu | |
TR201720406A2 (tr) | Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar | |
TR201721824A2 (tr) | Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon | |
CL2019002115S1 (es) | Estructura de detonador. | |
TR201818986A2 (tr) | İvabradi̇n ve metoprolol i̇çeren kati oral farmasöti̇k kompozi̇syonlar | |
TR201818864A2 (tr) | Di̇meti̇l fumarat ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon | |
TR201722970A2 (tr) | Flurbi̇profen-li̇dokai̇n ve seti̇lpi̇ri̇di̇nyum i̇çeren farmasöti̇k bi̇leşi̇mler | |
TR201818859A2 (tr) | Di̇meti̇l fumarat ve en az bi̇r kas gevşeti̇ci̇ ajan i̇çeren bi̇r kombi̇nasyon | |
TR201713954A2 (tr) | Tenofovir, emtrisitabin ve efavirenzin farmasötik kombinasyonlari | |
TR201910339T4 (tr) | Mala. | |
FR3033401B1 (fr) | Obus d'artillerie explosif bicomposants | |
MA56506A (fr) | Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées |